Literature DB >> 20640597

Risk of aggressive breast cancer in women of Han nationality carrying TGFB1 rs1982073 C allele and FGFR2 rs1219648 G allele in North China.

Xiao-Hui Chen1, Xiao-Qing Li, Ying Chen, Yu-Mei Feng.   

Abstract

The high morbidity and aggressive behavior of breast cancer are associated with genetic variations. Single nucleotide polymorphisms (SNPs) in many genes have been demonstrated as a risk factor for breast cancer. In this study, we evaluated the association of the SNP rs1982073 (Leu10Pro) in transforming growth factor-beta 1 (TGFB1) gene and the SNP rs1219648 in fibroblast growth factor receptor 2 (FGFR2) gene with the risk and aggressiveness of breast cancer among women of Han nationality in North China. TaqMan allelic discrimination assay was performed to genotype rs1982073 and rs1219648 in 447 breast cancer cases and 406 age-matched healthy controls. The results imply that genotype frequencies of rs1982073 and rs1219648 were not significantly different between breast cancer patients and healthy controls. However, for TGFB1 SNP rs1982073, the C-carriers (T/C+C/C genotype) were more likely to bear tumors of greater aggressiveness (histological grade III) than T/T-carriers (grade I-II) (OR = 3.45, 95% CI: 1.48-8.00, P = 0.004). For FGFR2 SNP rs1219648, G-carriers (A/G+G/G genotype) were more significantly linked to tumors with lymph node metastasis than those with A/A genotype (lymph node negative) (OR = 1.69, 95% CI: 1.11-2.58, P = 0.016). Therefore, the SNPs of TGFB1 rs1982073 and FGFR2 rs1219648 may contribute to the identification of patients with more aggressive breast cancers among Han women in North China.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20640597     DOI: 10.1007/s10549-010-1032-7

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  7 in total

1.  The GSTP1 105Val allele increases breast cancer risk and aggressiveness but enhances response to cyclophosphamide chemotherapy in North China.

Authors:  Jie Ge; Ai-Xian Tian; Qing-Shan Wang; Peng-Zhou Kong; Yue Yu; Xiao-Qing Li; Xu-Chen Cao; Yu-Mei Feng
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

2.  A study on genetic variants of Fibroblast growth factor receptor 2 (FGFR2) and the risk of breast cancer from North India.

Authors:  Sarah Siddiqui; Shilpi Chattopadhyay; Md Salman Akhtar; Mohammad Zeeshan Najm; S V S Deo; N K Shukla; Syed Akhtar Husain
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

3.  Plasma levels and tissue expression of soluble TGFβrIII receptor in women with early-stage breast cancer and in healthy women: a prospective observational study.

Authors:  Lovorka Grgurevic; Ruder Novak; Vladimir Trkulja; Stela Hrkac; Grgur Salai; Josko Bilandzic; Lejla Ferhatovic Hamzic; Ivan Milas; Tiha Vucemilo; Melita Peric Balja; Karmen Bilic
Journal:  J Transl Med       Date:  2020-12-11       Impact factor: 5.531

Review 4.  Hereditary breast cancer in the Han Chinese population.

Authors:  Wenming Cao; Xiaojia Wang; Ji-Cheng Li
Journal:  J Epidemiol       Date:  2013-01-12       Impact factor: 3.211

5.  Association of FGFR2 and PI3KCA genetic variants with the risk of breast cancer in a Chinese population.

Authors:  Yang Wang; Haiyu Zhang; Mingzhen Lin; Yongsheng Wang
Journal:  Cancer Manag Res       Date:  2018-05-21       Impact factor: 3.989

6.  Association between rs11200014, rs2981579, and rs1219648 polymorphism and breast cancer susceptibility: A meta-analysis.

Authors:  Yafei Zhang; Hongwei Lu; Hong Ji; Le Lu; Pengdi Liu; Ruofeng Hong; Yiming Li
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

7.  DOT: Gene-set analysis by combining decorrelated association statistics.

Authors:  Olga A Vsevolozhskaya; Min Shi; Fengjiao Hu; Dmitri V Zaykin
Journal:  PLoS Comput Biol       Date:  2020-04-14       Impact factor: 4.475

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.